Best CAR-T Treatment Hospitals Worldwide

Fortis La Femme, Greater Kailash II employs modern cell immunotherapy technology and evidence-based cancer treatment in CAR-T Cell Therapy. Founded in 2004, the NABH accredited hospital is located in Delhi, India and has 38 beds and facilities for local and international patients.

CAR-T Cell Therapy involves extracting T cells and processing them to recognise a specific cancer antigen before increasing their number in the body. Depending on the cancer treatment used, patients may undergo lymphodepleting chemotherapy before receiving CAR-T cells. The multidisciplinary team assesses all aspects of the disease, past treatment regimens, organ function, and suitability for treatment.

Jimenez Diaz Foundation University Hospital has advanced infrastructure for cellular therapy and provides CAR T-cell therapy to patients with specific types of blood cancers. The ISO, JCI accredited establishment of the year 1935 is situated in Madrid, Spain, and contains 686 beds.

CAR-T therapy is a form of immunotherapy in which the patient's immune system is engineered to target and destroy cancerous cells. The execution of the therapy involves cell collection, laboratory enhancement processes, chemotherapy, and infusion. Patients are monitored carefully before, during, and after treatment, as they may experience immune-related complications.

Medical Park Gebze Hospital has advanced infrastructure for cellular therapy and provides CAR T-cell therapy to patients with specific types of blood cancers. The JCI accredited establishment of the year 2015 is situated in Kocaeli, Turkey, and contains 120 beds.

CAR-T therapy is a form of immunotherapy in which the patient's immune system is engineered to target and destroy cancerous cells. The execution of the therapy involves cell collection, laboratory enhancement processes, chemotherapy, and infusion. Patients are monitored carefully before, during, and after treatment, as they may experience immune-related complications.

Quironsalud Marbella Hospital employs modern cell immunotherapy technology and evidence-based cancer treatment in CAR-T Cell Therapy. Founded in 1979, the ISO accredited hospital is located in Marbella, Spain and has 120 beds and facilities for local and international patients.

CAR-T Cell Therapy involves extracting T cells and processing them to recognise a specific cancer antigen before increasing their number in the body. Depending on the cancer treatment used, patients may undergo lymphodepleting chemotherapy before receiving CAR-T cells. The multidisciplinary team assesses all aspects of the disease, past treatment regimens, organ function, and suitability for treatment.

The Hannibal International Clinic is equipped with innovative CAR-T Cell Therapy, employing cutting-edge cellular immunotherapy methodologies in compliance with widely accepted global protocols for patient treatment. Founded in 2007, the certified hospital is situated in Tunis, Tunisia, offering specialised cancer treatment services to both local and international clientele, with a total bed count of 120.

CAR-T treatment is a personalised treatment process where a patient’s T cells are extracted, subsequently modified so that they can identify tumors in a patient’s body. The treatment process is indicated for some blood cancers, particularly some types of lymphomas, leukemias, and multiple myeloma. Medical professionals conduct various tests to determine a patient’s prior treatments, health status, and diagnoses before initiating the CAR-T treatment program.

Vinmec Phu Quoc Hospital uses advanced cellular manufacturing techniques and immunotherapy protocols to provide CAR T-cell therapy services. Founded in 2015, this institution is based in Phu Quoc, Vietnam, and has 150 beds, with JCI recognition, to assist both local and foreign patients.

The CAR-T process is beneficial for some patients with blood cancers that have failed prior treatment and returned, depending on the disease type and the approved indication. In CAR-T therapy, T cells are collected, engineered to recognise cancer cells, multiplied, and then infused back after proper preparation of the cells. The cancer treatment team performs a careful assessment of the disease and health history before individualisation of treatment.

Vinmec Times City employs modern cell immunotherapy technology and evidence-based cancer treatment in CAR-T Cell Therapy. Founded in 2012, the JCI accredited hospital is located in Ha noi, Vietnam and has 500 beds and facilities for local and international patients.

CAR-T Cell Therapy involves extracting T cells and processing them to recognise a specific cancer antigen before increasing their number in the body. Depending on the cancer treatment used, patients may undergo lymphodepleting chemotherapy before receiving CAR-T cells. The multidisciplinary team assesses all aspects of the disease, past treatment regimens, organ function, and suitability for treatment.

Casa di Cura La Madonnina uses advanced cellular manufacturing techniques and immunotherapy protocols to provide CAR T-cell therapy services. Founded in 1958, this institution is based in milan, Italy, and has 560 beds, with SSN recognition, to assist both local and foreign patients.

The CAR-T process is beneficial for some patients with blood cancers that have failed prior treatment and returned, depending on the disease type and the approved indication. In CAR-T therapy, T cells are collected, engineered to recognise cancer cells, multiplied, and then infused back after proper preparation of the cells. The cancer treatment team performs a careful assessment of the disease and health history before individualisation of treatment.

The Czech Medical Center is equipped with innovative CAR-T Cell Therapy, employing cutting-edge cellular immunotherapy methodologies in compliance with widely accepted global protocols for patient treatment. Founded in 1996, the JCIcertified hospital is situated in Brno, Czechia, offering specialised cancer treatment services to both local and international clientele, with a total bed count of .

CAR-T treatment is a personalised treatment process where a patient’s T cells are extracted, subsequently modified so that they can identify tumors in a patient’s body. The treatment process is indicated for some blood cancers, particularly some types of lymphomas, leukemias, and multiple myeloma. Medical professionals conduct various tests to determine a patient’s prior treatments, health status, and diagnoses before initiating the CAR-T treatment program.

Fortis Hospital employs modern cell immunotherapy technology and evidence-based cancer treatment in CAR-T Cell Therapy. Founded in 2001, the NABH, NABL, JCI accredited hospital is located in Bangalore, India and has 375 beds and facilities for local and international patients.

CAR-T Cell Therapy involves extracting T cells and processing them to recognise a specific cancer antigen before increasing their number in the body. Depending on the cancer treatment used, patients may undergo lymphodepleting chemotherapy before receiving CAR-T cells. The multidisciplinary team assesses all aspects of the disease, past treatment regimens, organ function, and suitability for treatment.

The Fortis Hospital is equipped with innovative CAR-T Cell Therapy, employing cutting-edge cellular immunotherapy methodologies in compliance with widely accepted global protocols for patient treatment. Founded in 2011, the NABH, NABLcertified hospital is situated in Kolkata, India, offering specialised cancer treatment services to both local and international clientele, with a total bed count of 400.

CAR-T treatment is a personalised treatment process where a patient’s T cells are extracted, subsequently modified so that they can identify tumors in a patient’s body. The treatment process is indicated for some blood cancers, particularly some types of lymphomas, leukemias, and multiple myeloma. Medical professionals conduct various tests to determine a patient’s prior treatments, health status, and diagnoses before initiating the CAR-T treatment program.

Quironsalud Torrevieja Hospital employs modern cell immunotherapy technology and evidence-based cancer treatment in CAR-T Cell Therapy. Founded in 2006, the ISO accredited hospital is located in Torrevieja, Spain and has 119 beds and facilities for local and international patients.

CAR-T Cell Therapy involves extracting T cells and processing them to recognise a specific cancer antigen before increasing their number in the body. Depending on the cancer treatment used, patients may undergo lymphodepleting chemotherapy before receiving CAR-T cells. The multidisciplinary team assesses all aspects of the disease, past treatment regimens, organ function, and suitability for treatment.

NMC Specialty Hospital Al Salam uses advanced cellular manufacturing techniques and immunotherapy protocols to provide CAR T-cell therapy services. Founded in 1999, this institution is based in Riyadh, Saudi Arabia, and has 100 beds, with CBAHI recognition, to assist both local and foreign patients.

The CAR-T process is beneficial for some patients with blood cancers that have failed prior treatment and returned, depending on the disease type and the approved indication. In CAR-T therapy, T cells are collected, engineered to recognise cancer cells, multiplied, and then infused back after proper preparation of the cells. The cancer treatment team performs a careful assessment of the disease and health history before individualisation of treatment.

The University Hospital Quironsalud Madrid is equipped with innovative CAR-T Cell Therapy, employing cutting-edge cellular immunotherapy methodologies in compliance with widely accepted global protocols for patient treatment. Founded in 2006, the ISO, JCIcertified hospital is situated in Madrid, Spain, offering specialised cancer treatment services to both local and international clientele, with a total bed count of 575.

CAR-T treatment is a personalised treatment process where a patient’s T cells are extracted, subsequently modified so that they can identify tumors in a patient’s body. The treatment process is indicated for some blood cancers, particularly some types of lymphomas, leukemias, and multiple myeloma. Medical professionals conduct various tests to determine a patient’s prior treatments, health status, and diagnoses before initiating the CAR-T treatment program.

Dexeus University Hospital uses advanced cellular manufacturing techniques and immunotherapy protocols to provide CAR T-cell therapy services. Founded in 1973, this institution is based in Barcelona, Spain, and has 200 beds, with JCI recognition, to assist both local and foreign patients.

The CAR-T process is beneficial for some patients with blood cancers that have failed prior treatment and returned, depending on the disease type and the approved indication. In CAR-T therapy, T cells are collected, engineered to recognise cancer cells, multiplied, and then infused back after proper preparation of the cells. The cancer treatment team performs a careful assessment of the disease and health history before individualisation of treatment.